These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

129 related items for PubMed ID: 9881082

  • 1. [Late phase II trial of oral etoposide administered for 21 consecutive days in patients with cervical cancer. ETP 21 Study Group--Cervical Cancer Group].
    Ikeda M, Noda K, Hiura M, Tamaya T, Ozaki M, Hatae M, Ozawa M, Yamabe T, Tanaka K, Izumi R, Okada H, Ogita Y, Hoshiai H.
    Gan To Kagaku Ryoho; 1998 Dec; 25(14):2249-57. PubMed ID: 9881082
    [Abstract] [Full Text] [Related]

  • 2. [Early phase II trial of oral etoposide administered for 21 consecutive days in patients with cervical or ovarian cancer. ETP 21 Study Group--Cervical-Ovarian Cancer Group].
    Noda K, Tanaka K, Ozaki M, Hirabayasi K, Hasegawa K, Nishiya I, Yakushiji M, Izumi R, Tomoda Y, Ogita Y, Sugimori H, Yamabe T, Kudo R, Yajima A, Terashima Y, Fujii S, Suzuoki Y, Okada H, Kono I, Ochiai K, Yamamoto T, Ikeda M, Umesaki N, Saito T, Niitani H.
    Gan To Kagaku Ryoho; 1998 Nov; 25(13):2061-8. PubMed ID: 9838908
    [Abstract] [Full Text] [Related]

  • 3. [Late phase II study with 21-consecutive-day oral administration of etoposide for malignant lymphoma].
    Yoshida T, Takagi T, Shimoyama M, Mikuni C, Suzuki K, Egami K, Furusawa S, Nomura T, Mori M, Sugimoto T.
    Gan To Kagaku Ryoho; 1994 Dec; 21(16):2793-801. PubMed ID: 7993116
    [Abstract] [Full Text] [Related]

  • 4. [A phase II study of etoposide (VP-16) injection in primary lung cancer by cooperative study group].
    Kado M, Oshima S, Matsui Y, Shimokata K, Hara K, Kanda T, Shima K, Takenaka S.
    Gan To Kagaku Ryoho; 1986 Jan; 13(1):116-21. PubMed ID: 3002282
    [Abstract] [Full Text] [Related]

  • 5. [A phase II study of oral VP-16 in primary lung cancer].
    Matsui Y, Ohshima S, Kado M, Nakayama M, Shimokata K, Sakai S, Ito F, Chikata E, Hara K, Kanda T.
    Gan To Kagaku Ryoho; 1985 Sep; 12(9):1801-7. PubMed ID: 2994576
    [Abstract] [Full Text] [Related]

  • 6. [A phase II clinical study of cis-diammine glycolato platinum, 254-S, for cervical cancer of the uterus].
    Noda K, Ikeda M, Yakushiji M, Nishimura H, Terashima Y, Sasaki H, Hata T, Kuramoto H, Tanaka K, Takahashi T.
    Gan To Kagaku Ryoho; 1992 Jun; 19(6):885-92. PubMed ID: 1605666
    [Abstract] [Full Text] [Related]

  • 7. [Phase I clinical study of 21-consecutive-day oral administration of etoposide].
    Noda K, Fukuoka M, Komatsu H, Hayashihara K, Ariyoshi Y, Tanaka K, Nakajima H, Terashima Y, Nagao K, Furuse K.
    Gan To Kagaku Ryoho; 1994 Aug; 21(10):1633-9. PubMed ID: 8060139
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. [Early phase II study of oral administration of etoposide for 21 consecutive days in patients with non-small-cell lung cancer].
    Hayasaka S, Kinuwaki E, Nakabayashi T, Saito R, Komatsu H, Nishikawa H, Ohizumi K, Shimizu T, Nakai Y, Niitani H.
    Nihon Kyobu Shikkan Gakkai Zasshi; 1995 Dec; 33(12):1367-1371. PubMed ID: 8821989
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. A Phase I-II study of sequential administration of topotecan and oral etoposide (toposiomerase I and II inhibitors) in the treatment of patients with small cell lung carcinoma.
    Mok TS, Wong H, Zee B, Yu KH, Leung TW, Lee TW, Yim A, Chan AT, Yeo W, Chak K, Johnson P.
    Cancer; 2002 Oct 01; 95(7):1511-9. PubMed ID: 12237920
    [Abstract] [Full Text] [Related]

  • 15. Pilot study on induction chemotherapy with cisplatin, epirubicin, etoposide and bleomycin in cervical cancer stage Ib, IIa and IIb.
    Panetta A, Angelelli B, Martoni A.
    Anticancer Res; 1999 Oct 01; 19(1B):765-8. PubMed ID: 10216490
    [Abstract] [Full Text] [Related]

  • 16. Salvage chemotherapy for recurrent spinal cord ependymona.
    Chamberlain MC.
    Cancer; 2002 Sep 01; 95(5):997-1002. PubMed ID: 12209682
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Prolonged oral etoposide in recurrent or advanced non-squamous cell carcinoma of the cervix: a Gynecologic Oncology Group study.
    Rose PG, Blessing JA, Buller RE, Mannel RS, Webster KD.
    Gynecol Oncol; 2003 May 01; 89(2):267-70. PubMed ID: 12713990
    [Abstract] [Full Text] [Related]

  • 19. [Concurrent chemoradiation therapy with nedaplatin for high-risk cervical cancer--clinical investigation of adverse events].
    Kamiura S, Kobayashi K, Ohira H, Seino H, Hashimoto N, Sawai K, Samejima Y, Saji F.
    Gan To Kagaku Ryoho; 2001 Jul 01; 28(7):979-86. PubMed ID: 11478148
    [Abstract] [Full Text] [Related]

  • 20. A phase I study of paclitaxel, etoposide, and cisplatin in extensive stage small cell lung cancer.
    Kelly K, Pan Z, Wood ME, Murphy J, Bunn PA.
    Clin Cancer Res; 1999 Nov 01; 5(11):3419-24. PubMed ID: 10589753
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.